EGFR-IN-45
Product Specifications
Target
EGFR, Apoptosis, Others, Topoisomerase, CDK
Related Pathways
Cell Cycle/Checkpoint, Others, Tyrosine Kinase/Adaptors, Angiogenesis, DNA Damage/DNA Repair, JAK/STAT signaling, Apoptosis
Bioactivity
EGFR-IN-45 is a potent pan-inhibitor of the epidermal growth factor receptor (EGFR) with an IC50 of 0.4 μM and also targets CDK2 with an IC50 of 1.6 μM. It inhibits topoisomerases Topo I and Topo II, blocks the cancer cell cycle in the pre-G1 phase, and induces apoptosis.
Molecular Formula
C28H23N7O
Molecular Weight
473.53
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS8120224-01 0.05 mg
Syndecan-2 Protein, Human, Recombinant (ECD, His Tag)
Sign In for Pricing
View Details MBS8120224-02 0.5 mg
Syndecan-2 Protein, Human, Recombinant (ECD, His Tag)
Sign In for Pricing
View Details MBS8120224-03 5x 0.5 mg
Syndecan-2 Protein, Human, Recombinant (ECD, His Tag)
Sign In for Pricing
View Details 
